Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Angiogenesis and VEGF Signalling Research indicates BPC-157 may upregulate vascular endothelial growth factor (VEGF) pathways in experimental models, contributing to: Capillary formation Accelerated wound closure Improved microvascular repair Reference: Hsieh et al., 2017 Angiogenic mechanisms in BPC 157-treated tissues PubMed: 3
Source Quality BPC-157 isn't FDA-approved as a therapeutic drug
BPC-157 is short for Body Protective Compound. It is believed to work by stimulating angiogenesis (the formation of new blood vessels), collagen synthesis, and cellular repair
We dont recommend that approach and the reasons are specific, not just liability-driven
US$ 22.13
US$ 28.36
US$ 21.80
US$ 29.61
